Chk-336, a first-in-class orally administered ldh inhibitor: safety, pk and target engagement in a first-in-human phase 1 healthy volunteer studyVincent Tong,Brian Schwartz, Chun Lam,John Knight,Sonia Fargue, David A. Wagner,Harvey Wong, Lei Wang, Hetal Kocinsky, Valerie Fauvelle,Andrew KingNEPHROLOGY DIALYSIS TRANSPLANTATION（2023）引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
